Format

Send to

Choose Destination
Nat Rev Clin Oncol. 2018 Oct;15(10):596-597. doi: 10.1038/s41571-018-0066-3.

Reinforcing the social compromise of accelerated approval.

Author information

1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
2
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. akesselheim@bwh.harvard.edu.
PMID:
29970919
DOI:
10.1038/s41571-018-0066-3

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center